Académique Documents
Professionnel Documents
Culture Documents
http://journals.imed.pub
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Corresponding author:
Lawrence Ehis Okoror
LEOkoror@gmail.com
Methods and Findings: This study evaluates the risk exposure of individuals coming up with related symptoms using Enzyme Linked Immunosorbent Assay (ELISA) with Human Chlamydia IgM. A total of 699
individuals were screened of which 91.2% were positive for Chlamydia
trachomatis IgM Age group 21-30 years had the highest prevalence
which was followed by 11-20 years. Sociodemographic characteristics
show that Chlamydia trachomatis infection is associated with age,
high sexual activity, multiple sex partners, low socioeconomic status,
unprotected sex and sex orientation. Males and females had equal
chances of contacting the infection.
Conclusion: Screening of individuals in routine clinical environment
should be made a policy especially with related symptoms and should
be followed by education of the population on the risk as well as
increased education on sexually transmitted infections.
Introduction
Chlamydia trachomatis(CT) causes the commonest
sexually transmitted diseases in the United States
and Europe [1,2] with approximately 4 million cases
reported each year in the USA alone with paucity
of information about the pathogen in Nigeria and
other sub-Saharan Africa. Wilson et al. [3] reported
that the highest prevalence in the USA is in people
<25 years of age. Information about relative frequency of CT in Nigeria is sparse [4]. However, some
studies have implicated Chlamydia trachomatis as a
major cause of infections in Africa.
Okoror et al. [5] reported them as a likely cause
of complications in patients visiting gynecological
clinics in South East Nigeria which included both
males and females visiting prenatal clinics for infertility cases and concluded that CT may have been
involved in complications resulting in infertility of
either males or females. Brunham et al. [6] had earlier reported that CT would be a major problem in
Africa as its population begins to grow and therefore recommended more researches in sub-Saharan
Africa in order to provide preventive and also prophylaxis knowledge needed to arrest the growth of
this organism.
Sturm-Ramirez et al. [7] reported high prevalence
of CT in asymptomatic commercial sex workers in
Senegal with genotype E predominating and the
women had no visible signs of infection. A major
problem with CT infection is its ability to remain
latent for a very long time [8] and then comes with
very serious sequelae if left untreated. Such sequelae can include pelvic inflammatory diseases (PID),
cervicitis, salpingitis, endometritis and infertility [9].
Though the effect of CT infection in females has
been given more attention, it is also a cause of
very serious infection in males which included urethritis, epididymitis and sometimes reactive arthritis.
Okoror and Agbonlahor, [10] reported that CT could
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Results
Of the total of 699 symptomatic individuals
screened for Chlamydia trachomatis (CT) infection,
546 (91.2%) were positive for CT IgM using the
ELISA technique of which 221 (40.5%) were males
and 325 (59.5%) were females. The mean age of
the positive individuals was 21.5 years.
Their sociodemographic data and characteristics are
shown in table 1. Age group 21-30 had the highest
number of participants and the highest prevalence
of 0.880 other age groups also have high preva Under License of Creative Commons Attribution 3.0 License
2014
Vol. 5 No. 5:2
doi: 10.3823/285
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Total
Age (years)
Prevalence
Odd Ratio
Crude
Adj.
Crude
Adj
11-20
88
0.852
0.836
5.769
5.099
21-30
322
0.877
0.880
7.150
7.364
36-40
150
0.873
0.849
6.895
5.621
41-50
63
0.825
0.831
4.727
4.903
51-60
78
0.765
0.834
3.250
5.020
P value
Sig. F
chi
Coef. Of
corr.
Inter.
W.
mean
W.
SD
CI (95%)
0.084
0.002
2.99
0.501
1.491
0.839
0.041
0.89001.2593
0.95
0.050
1.528
0.871
0.061
0.35702.1845
2.99
0.291
1.462
0.868
0.053
0.75521.5009
15.16
0.558
0.781
0.104
1.045161.0512
315
0.892
0.870
8.265
6.682
Ibo
144
0.847
0.845
5.546
5.749
Hausa
24
0.955
0.826
21
4.749
Minority
218
0.789
0.856
3.739
5.963
0.329
0.036
163
0.810
0.844
4.258
5.408
Study
380
0.884
0.880
7.636
7.302
Not working
132
0.833
0.838
5.181
Declined
19
0.947
0.816
18
4.431
0.084
0.017
SE = ; Slope = 0.0014
Marital Staus
Married
326
0781
0.863
3.567
6.301
Never Married
380
0.947
0.895
18
12.477
Co-habiting
11
0.727
0.891
2.667
0.414
Decline
0.667
0.834
0.406
NaN
0.0001
SE = ; Slope = 0.0092
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Age
Characteristics.
Total
Prevalence
Crude
Age (years)
Adj.
P value
Odd Ratio
Crude
Sig. F
chi
Coef. Of
corr.
Inter.
W.
mean
W.
SD
CI (95%)
2.46
0.116
1.514
0.870
0.063
0.09842.1273
2.7
0.934
1.747
0.8821
0.034
1.02321.14045
27.96
0.230
0.874
0.069
1.716
0.8465
0.0002
Adj
Socioeconomics
High Income
128
0.75
0.863
6.322
Mid. Income
243
0.868
0.895
6.594
8.505
Low Income
229
0.930
0.891
13.313
8.204
Decline
40
0.9
0.834
5.039
0.117
0.046
SE = ; Slope = 0.0026
Education
University
261
0.957
0.917
10.864 11.043
Secondary
282
0.922
0.921
11.818
11.641
Primary
56
0.857
0.868
6.601
Not Educated
34
0.882
0.862
7.5
6.246
Decline
0.833
0.853
5.793
0.111
0.0002
SE = ; Slope = 0.0025
Length of stay
6 months
456
0.943
0.943
16.53
16.53
6 months
243
0.805
0.805
4.122
4.122
<0.0001
Slope = 0.0056
Sex
Male
261
0.8467 0.8467
5.525
5.525
Female
384
NAN
Key: Sig. F = significance of Fishers test, w. mean= weighted mean, w. SD = weighted standard deviation, inter. = interval of
the slope of the regression line, coef. Corr. = Coefficient of correlation, CI = confidence interval. Adj.= adjusted.
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Discussion
2014
Vol. 5 No. 5:2
doi: 10.3823/285
Table 2. L ogistic regression analysis of behavioral characteristics of symptomatic individuals screened for
Chlamydia trachomatis IgM
Characteristics.
Total
Heavy Drinking
Prevalence
Odd Ratio
Crude
Adj.
Crude
Adj
Yes
217
0.461
0.523
0.855
0.096
No
355
0.642
0.622
1.795
1.644
Decline
27
0.593
0.386
1.455
0.627
P value
Sig. F
chi
Coef.
Of corr.
Inter.
W.
mean
W.
SD
CI (95%)
0.002
0.134
9.42
0.525
0.546
0.565
0.077
-2.58765.60475
Slope = 0.0029
Age at First Sex
11-20
82
0.824
0.881
4.125
7.371
36-40
196
0.869
0.804
6.539
4.111
21-35
321
0.654
0.684
1.892
2.166
0.782
3.125-3.125
Slope =
Number of Sexual Partners
1
178
0.320
0.572
0.471
1.334
1-3
191
0.686
0.539
2.183
1.170
<3
95
0.884
0.756
7.636
3.091
None
122
0.746
0.702
2.935
2.351
Decline
27
0.519
0.860
1.077
6.148
0.228
2.089
0.7022
0.1348
0.47892.2505
23.21
0.417
0.623
0.7022
0.1348
6.2352946.235294
28.67
0.8267
0.5415
0.7164
0.1594
1.0181821.018182
48.76
0.725
2.521
0.7248
0.1275
Slope = 0.0101
Condom Use
Yes
193
0.513
0.675
1.053
2.078
No
306
0.817
0.821
4.464
4.592
Infrequent
200
0.777
0.686
3.478
2.182
<0.0001
NAN
Slope = 0.007
Sex Orientation
Heterosex
455
0.879
0.850
7.273
7.349
Homosex
44
0.5
0.664
1.978
Bisexual
100
0.77
0.703
3.348
2.365
Yes
234
0.829
0.753
4.85
3.055
No
365
0.545
0.582
1.199
1.393
Decline
100
0.8
0.872
6.826
<0.0001
NAN
Slope = 0.0032
Regular Abortion
0.0001
NAN
Slope= 0.006
Under License of Creative Commons Attribution 3.0 License
2014
Vol. 5 No. 5:2
doi: 10.3823/285
2014
Vol. 5 No. 5:2
doi: 10.3823/285
10
2014
Vol. 5 No. 5:2
doi: 10.3823/285
References
1. Schillinger JA, Dunne EF, Chapin JB, Ellen JM, Gaydos CA,
Willard NJ, Kent CK, Marrazzo JM, Klausner JD, Rietmeijer CA,
Markowitz LE Prevalence of Chlamydia trachomatis infection
among men screened in 4 U.S. cities. Sex Transm Dis, 2005;
32:74-77.
2. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs
MM, Cohen MS, Harris KM, Udry JR Prevalence of chlamydial
and gonococcal infections among young adults in the United
States. JAMA, 2004; 291:2229-2236.
3. Wilson JS.,HoneyE,Templeton A.,Paavonen J,Mardh, PA, Stary
A.andStray-Pedersen, B A systematic review of the prevalence
of Chlamydiatrachomatisamong European women. Journal of
Human Reproduction Update 2000; 8 (4): 385-394.
4. Tukur J,Shittu, SO and Abdul AM. A case control study of active
genital Chlamydia trachomatis infection among patients with
tubal infertility in northern Nigeria. Journal of Tropical Doctors.
2006; 36 (1): 14-16.
5. Okoror LE, Agbonlahor DE, Esume FI and Umolu P.I Prevalence
of Chlamydia in patients attending gynaecological clinics in
South Eastern Nigeria. African Health Sciences 2007; 7 (1) 1824.
6. Brunham RC,Cheang M,McMaster J,Garnett G,Anderson R.
Chlamydia trachomatis, infertility, and population growth in
sub-Saharan Africa. Sex Transm Dis. 1993; 168-73.
7. Sturm-Ramirez K.; Brumblay H, Diop K, Guye-Ndiaye, A,
Sankal, J, Thior I, NDoye I, Hsieh C, Mboup S, Kanki P
Molecular epidemiology of genital Chlamydia trachomatis
infection in high-risk women in Senegal, West Africa. Journal of
Clinical Microbiology, 2000; Vol.38, No.1, pp. 138
8. Nelson HD and Helfand, M.et. al. Screening for chlamydial
infection. American Journal of Prevntive Medicine. 2001; 20
(3): 95-107.
9. Bennett S, McNicholas A. and Garrett N. Screening and
diagnostic practices for Chlamydia infections in New Zealand.
New Zealand Medical Journal 2001; 114:349352.
10. Okoror LE and Agbonlahor DE High Prevalence of Chlamydia
Trachomatis in the Sperm of Males with Low Sperm Count in
2014
Vol. 5 No. 5:2
doi: 10.3823/285
http://medicalia.org/
Where Doctors exchange clinical experiences,
review their cases and share clinical knowledge.
You can also access lots of medical publications for
free. Join Now!
11